August 7, 2023 06:12 AM EDT

FDA approves second geographic atrophy drug but caps use period, as Astellas’ Iveric looks to spar with Apellis

Iveric Bio secured an FDA approval for its geographic atrophy treatment on Friday evening, marking the second drug that’s been cleared …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA ap­proves sec­ond ge­o­graph­ic at­ro­phy drug but caps use pe­ri­od, as Astel­las’ Iver­ic looks to spar with Apel­lis